Breakthrough funding to boost biotech startups

Published: 23 November 2021

Biotech startups in Melbourne are set to benefit from a new incubator in Parkville thanks to a substantial investment from the Victorian Government’s Breakthrough Victoria Fund.

The fund’s first investment will help local startups overcome barriers to turning ideas into commercial outcomes by providing vital access to sophisticated technology platforms and expert technical support.

The new incubator – worth a total of $95 million – will have capacity to host up to 40 biotech startups at a time and provide unparalleled access to industry expertise, academic and clinical facilities and infrastructure, as well as essential capital.

In addition to the Breakthrough Victoria contribution, the incubator will be funded by world leaders in biotech and health sciences CSL, the Walter and Eliza Hall Institute and the University of Melbourne, as a consortium formed to accelerate biotech commercialisation.

It will be located within the Parkville Biomedical Precinct and capitalises on the infrastructure investments made in the Parkville National Employment and Innovation Cluster (NEIC), which includes 30 world-class hospitals, medical research institutes, cooperative research centres and universities.

Breakthrough Victoria is an independently operated, government owned company managing the $2 billion Breakthrough Victoria Fund.

It is actively seeking investment proposals to mobilise innovation in key industry sectors such as health and life sciences, agri-food, advanced manufacturing, clean economy and digital technologies.

Victoria’s medical research sector supports more than 30,000 jobs across institutes, universities and industry, with more than 40 per cent of Australian-based biotechnology and medical technology companies calling Melbourne home.  Learn more via the Medical Research website.